FDA NDC Directory · JSON-LD · Markdown

ANDEXXA

NDC 0310-3200 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameandexanet alfa
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA125586
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsANDEXANET ALFA (200 mg/20mL)
Marketing started20220712
Marketing ended20271231
Package count2

External sources

Source: openFDA. Public-domain (CC0).